Effects of wrist limited dynamic splint on carpal tunnel syndrome

Effects of wrist limited dynamic splint on the upper extremity function of women with carpal tunnel syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015061522753N1

Enrollment

Registered

2015-11-27

Start date

2015-06-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: The treatment group would receive routine rehabilitation treatment beside the wrist limited dynamic splint. Intervention 2: the control group would receive routine rehabilitation tre

Rehabilitation

The treatment group would receive routine rehabilitation treatment beside the wrist limited dynamic splint

the control group would receive routine rehabilitation treatment without splint

Eligibility

Sex/Gender

Female

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the subjects gender should be female; the patients diagnosis should be carpal tunnel syndrome by a physiatrist doctor; the severity of illness should be mild or moderate; the subjects should be able to understand and do the orders of the tests. Exclusion criteria: history of surgery on the affected hand; systemic illnesses; pregnancy; subjects who do not cooperate; subjects who do not have the results of neural conductive tests.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Function. Timepoint: Before and after the 6 weeks treatment. Method of measurement: Boston carpal tunnel syndrome questionnaire.;Symptome severity. Timepoint: Before and after the 6 weeks treatment. Method of measurement: Boston carpal tunnel syndrome questionnaire.;Grip strength. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MIE digital device.;Pinch strength. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MIE digital device.;Dexterity. Timepoint: Before and after the 6 weeks treatment. Method of measurement: Purduepeg board test.;Median nerve sensory conductive velocity. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MEDLEC SYNERGY VIASIS electromiography device.;Median nerve distal sensory latency. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MEDLEC SYNERGY VIASIS electromiography device.	—

Measure

Time frame

Function. Timepoint: Before and after the 6 weeks treatment. Method of measurement: Boston carpal tunnel syndrome questionnaire.;Symptome severity. Timepoint: Before and after the 6 weeks treatment. Method of measurement: Boston carpal tunnel syndrome questionnaire.;Grip strength. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MIE digital device.;Pinch strength. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MIE digital device.;Dexterity. Timepoint: Before and after the 6 weeks treatment. Method of measurement: Purduepeg board test.;Median nerve sensory conductive velocity. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MEDLEC SYNERGY VIASIS electromiography device.;Median nerve distal sensory latency. Timepoint: Before and after the 6 weeks treatment. Method of measurement: MEDLEC SYNERGY VIASIS electromiography device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyede Marjan Jaladat

Tehran University of Medical Sciences

jaladatot@gmail.com; m-jaladat@razi.tums.ac.ir+98 71 3225 5978

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026